All In MedTech

Device Trial Radar · NCT07164040

Leica Microsystems Sponsored Study to Collect and Confirm Clinical Data on the Performance of the GLOW800 Device When Used in Accordance With Its Intended Use.

Fluorescence Visualization and Image Quality Evaluation of Digital Visualization During Standard of Care Procedure in the Cerebral Vascular Area as Well as Blood Flow During Plastic and Reconstructive Surgery (PRS) (Leica GLOW800)

Last checked: Nov 20, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

31

Planned (sponsor's estimate)

Start

Jan 8, 2026

Primary completion

Nov 30, 2026

Study completion Jul 30, 2027

Sponsor

Lead sponsor
Leica Microsystems (Schweiz) AGNot on our public-company list
Sponsor type
Industry
First posted
Sep 9, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This post-market clinical follow-up (PMCF) study aims to confirm the safety and performance of the GLOW800 surgical microscope accessory when used in conjunction with the ARveo8x surgical microscope. The study evaluates fluorescence visualization and image quality during standard surgical procedures in the cerebral vascular area and plastic and reconstructive surgery. It is a non-interventional, observational study conducted in routine care settings across multiple European sites.

Conditions

  • Reconstructive Surgical Procedures
  • Plastic Surgery
  • Vascular Surgical Procedure
  • Cerebrovascular Disorder

Interventions

  • The GLOW800, a non-contact, non-invasive device, allows the surgical microscope ARveo 8 and ARveo 8X to produce excitation light and resolve fluorescence emission from the fluorescent agent ICGDevice

    When activating the GLOW800 mode, the white light illumination of the Leica microscope stand is extended to InfraRed (IR), to excite the fluorophore (ICG). The technology provides ergonomic advantages as the user can maintain an upright posture while observing the surgical field. To excite the fluorophore, ICG dye is illuminated with light at its excitation wavelength band around 750 - 800nm. GLOW800 utilizes a 400w xenon illumination light source integrated as a standard component within the compatible Surgical Operating Microscope (SOM) stand. Activation of the GLOW800 mode extends the white light illumination of the SOM to the infrared (IR) spectral range using a suitable filter placed in the compatible SOM's standard filter wheel for the excitation of the ICG. Each patient enrolled in this study will undergo standard of care for the surgical procedure. No deviations to the standard of care will occur in the execution of this study.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Fluorescence visibility.Time frame: Periprocedural
  2. Image qualityTime frame: Periprocedural
  3. Anatomical backgroundTime frame: Periprocedural

1 more outcomes with a free account

Locations

3 sites in 3 countries. Site status is shown where the registry gives one.

  • Unidade Local de Saúde de São João

    Porto, Portugal · Recruiting

  • Hospital Germans Trias I Pujol

    Barcelona, Spain · Recruiting

  • University Hospital Basel

    Basel, Switzerland · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.